
æ°åã³ãããŠã€ã«ã¹ã«ãäººã®æãå ¥ã£ãŠãããšãã蚌æ ãå»åŠèªã®è«æã«ããçºèŠïŒ
æ°åã³ãããŠã€ã«ã¹ã«ãäººã®æãå ¥ã£ãŠãããšãã蚌æ ãåºãŠããŸããã
è¶ ç°¡åã«èŠçŽãããšããããªããŸãã
ã¢ã¡ãªã«ã®åœå®¶æ©é¢ã倧åŠã«è³éãæäŸããŠããŠã€ã«ã¹ã«äººéãæãå ããŠãåãããªãããã«ããæè¡ãéçºãããã
ã§ãããã®æè¡ã¯äžå®å šã§ãæãå ããããšã¯åãããªããŠãããã®æè¡ã䜿ã£ã蚌æ ãæ®ããããªãã®ã ã£ãã
ãããŠããã®æè¡ã䜿ã£ã蚌æ ããæ°åã³ãããŠã€ã«ã¹ããçºèŠããããšãããã®ã§ãã
äžçïŒå€§å»åŠèªã®ã©ã³ã»ããèªïŒLancetïŒãã³ããå§å¡äŒãèšçœ®ããŠãïŒïŒã¶æã®èª¿æ»ã®æ«ã«åèªã«æåºããè«æã«ããçºèŠããŸããã
ç ç©¶è ãã¡ã¯ãäœè ãã«ãããããã®è¡åã®è£ã«ã¯ãæªæãæã£ãæå³ããã£ãã®ã§ã¯ç¡ãããšçã£ãŠããŸãã
ãã¡ãã®èšäºã§è©³ãã解説ãããŠããã®ã§ã翻蚳ããŠãããŸãã
ïŒåŒçšããããïŒ
ã³ãããŠã€ã«ã¹ã®èµ·æºã調æ»ããæ¹è©å®¶ãã¡ã¯ããªãç±³åœç«è¡çç ç©¶æïŒNIHïŒããããŒã¹ã«ãã©ã€ã倧åŠãã£ãã«ãã«æ ¡ïŒUNCïŒã®ã©ã«ãã»ããªãã¯ææã«è³éãæäŸããŠããŠã€ã«ã¹ã«äººéãæãå ãã蚌æ ãé ãæè¡ãéçºãããã®ããé·ãéçåèŠããŠããŸããã
ããªãã¯ææã¯ãç±³åœç«ã¢ã¬ã«ã®ãŒææçç ç©¶æïŒNIAIDïŒïŒNIHã®åäžã§ãæ°åã³ããã¯ã¯ãã³ã®ç ç©¶éçºã«é¢äžïŒããæäŸãããçŽ2å2050äžãã«ã®è³éã«ããããã·ãŒã ã¬ã¹ã»ã©ã€ã²ãŒã·ã§ã³ããšèšãåã®æè¡ãéçºããå®éšå®€ã§ãŠã€ã«ã¹ã«äººéãæãå ãã蚌æ ãå®å šã«é èœã§ãããšèªæ ¢ããŠããŸããã
ããªãã¯ææã¯ãã®çºæããããŒã»ã·ãŒãšã æ³ãïŒno-seeâmã圌ãã¯èŠããªãã®æå³ïŒãšåã¥ããŸããã
çŸåšããã¬ããªã³ãã»ãµãŒããŒïŒæ»èªåã®è«æãä¿ç®¡ãå ¬éããå ŽæïŒã®bioRxivã§å ¬éãããŠããæ°ããç ç©¶ãEndonuclease fingerprint shows a synthetic origin of SARS-CoV2ãïŒãšã³ããã¯ã¬ã¢ãŒãŒã®ãã£ã³ã¬ãŒããªã³ãããSARS-CoV2ã®åæèµ·æºã倿ïŒãæå³ãããšããã¯ããã·ãŒã ã¬ã¹ã»ã©ã€ã²ãŒã·ã§ã³ãæè¡ã®é èœå·¥äœã¯ãããªãã¯ææãæå³ãšã¯å¥ã«ã埮现ã ãèªã¿ããããµã€ã³ãæ®ããŠããŸããšèšãããšã瀺ããŠããŸãããã
æã泚ç®ãã¹ãããšã¯ããã®ç ç©¶è
ãã¡ã¯ãæ°åã³ããã®åå ãŠã€ã«ã¹ã®DNAã²ãã ã«ããã®å¿ãŸãããé èœå·¥äœãè¡ããããšèšããµã€ã³ãçºèŠããããšã§ãã
ããªãã¯ææã®æè¡ã«ã¯é·ãéç°è«ããããŸããã
æ°åã³ããã®èµ·æºã調æ»ããããã«çµæãããå§å¡äŒã§ãããã©ã³ã»ããã»ã³ããå§å¡äŒãã®è°é·ã§ãããžã§ããªãŒã»ãµãã¯ã¹å士ã¯èšããŸãã
ãçµµç»ã«ãµã€ã³ãããªãèžè¡å®¶ããããŠã€ã«ã¹åŠè ããŠã€ã«ã¹ã«ãµã€ã³ãããªãã®ã¯ããããèªç¶ã«åºçŸãããã®ãå®éšå®€ã§äœããããã®ããç¥ãããããªãããã§ããã
ããã®ãã¹ãŠããæ¬åœã«å€§ããªãéåžžã«å±éºãªç 究課é¡ãé²è¡äžã§ãã£ãããšã瀺ããŠããŸããã
仿ãµãã¯ã¹å士ã¯ãæ°åã³ããã¯ããããå®éšå®€ã§äœããããã®ã§ããã®æè¡ã¯NIHãè³éæäŸããŠéçºããç§åŠæè¡ã«ç±æ¥ãããšãããäžå©ãªçµè«ãå«ã22ã¶æã®èª¿æ»çµæãã©ã³ã»ããèªã«çºè¡šããŸããã
é²åçç©åŠè ã®ãã¬ããã»ã¯ã€ã³ã¹ã¿ã€ã³å士ã¯ãããªãã¯ææã®ã·ãŒã ã¬ã¹ã»ã©ã€ã²ãŒã·ã§ã³æ³ã«ã€ããŠãããè¿°ã¹ãŠããŸãã
ã圌ããã£ãããšã¯ã人ã ã®å ¬è¡è¡çã«é¢å¿ããã人ãããããšãšã¯æ£å察ã§ãã
å ¬è¡è¡çåŠã®ç ç©¶è ãªããèªåã®ç ç©¶ææãåããããã瀺ãããããé ãæ¹æ³ãèæ¡ãããããªãã§ãããã
ãããé ãããã®ã¯ãéæ³ãªçç©å µåšã®éçºãªã©ãç§åŠè ãèªåã®ç 究宀ãŸã§è¶³è·¡ã蟿ãããããªãæªäºãé²ãããããªã®ã§ããã
ããªãã¯ææã¯2016幎ã«ãæŠæŒ¢ãŠã€ã«ã¹ç ç©¶æïŒWIVïŒã®ãã³ãŠã¢ãªå¥³ãã·ãŒã»ãŒã³ã°ãªå士ã«ãããŒã·ãŒãšã ãæ³ãäŒæããŸããã
ãã®èŠè¿ããšããŠãããªãã¯ææã¯ã·ãŒå士ãé²åçã®ã³ãŠã¢ãªããæ¡åããäžåœç£ã³ãããŠã€ã«ã¹ãåãåããŸããã
(ç§åŠè ãã¡ã¯ãæ°åã³ããã®ã²ãã ã®è¡çµ±ãè¿çžã®ã³ãŠã¢ãªãšçµã³ã€ããŠããŸã)ã
æŠæŒ¢ç ç©¶æã®ã·ãŒå士ãšåœŒå¥³ã®ååãã¡ã¯ããã®åŸãæŠæŒ¢ç ç©¶æã®äžé£ã®ïŒéåžžã«è°è«ãåŒãã ïŒæ©èœç²åŸå®éšãçºè¡šããããªãã¯ææã®å±éºæ§ã®é«ãæè¡ã䜿ãããªãããšãå®èšŒããŸããã
ããªãã¯ææã®æ¹å€è ã«ãšã£ãŠããã«äžå¯è§£ãªããšã¯ãããªãã¯ææãåã³ç±³åœç«ã¢ã¬ã«ã®ãŒææçç ç©¶æ(NIAID)ã®è³éæŽå©ãåããŠãç åäœãå µåšåããããšã®åºæ¥ãå±éºãªæè¡ããæããã«äžåœè»ãšç¹ããã®ããäžåœäººç§åŠè ãšå ±æããããšã«ããããšã§ããã
ïŒãªãæ°åã³ããã¯ã¯ãã³ãéçºæ¯æŽããNIAIDããäžåœè»ãå©ãããããªè¡åãåã£ãã®ã§ããããïŒïŒ
å°éå®¶ã«ããã°ããã®æ°ããç ç©¶ã¯åºç¯å²ã«åœ±é¿ãåãŒãå¯èœæ§ããããšããŠããŸãã
ããªãã¯ææã«æ³šç®ããããšã§ããã®ç ç©¶ã¯NIAIDãšããŒã¹ã«ãã©ã€ã倧åŠããã®ä»ã®é¢ä¿è ã«å£æ» çãªè²¬ä»»ãè² ãããå¯èœæ§ãæèµ·ããŠããŸãã
ã¢ã³ãœããŒã»ãã¡ãŠãå士ã«è¿ãç§åŠè ãã¡ã¯ãæ°åã³ããã®åå ãŠã€ã«ã¹ã§ããSARS-CoV-2ããèªç¶é²åãšççŸãããããªã²ãã é åãæã£ãŠããããšãç¹°ãè¿ãææããŠããŸããã
æ°åã³ãããŠã€ã«ã¹ã¯ããã¯ãã³ãŠã¢ãªã«ã¯ææããªããããã®ã¹ãã€ã¯ç¶ã®ã¿ã³ãã¯è³ªã®ç¹åŸŽïŒãã®ç³»åã®ã³ãããŠã€ã«ã¹ã§ã¯æªç¥ã§ããïŒã¯ãããã«çæ³çã«ææãããããªå€ãã®å€ç°ãå«ãã§ããã®ã§ãã
æãè¿ãæ¢ç¥ã®ã³ãããŠã€ã«ã¹ã§ããæŠæŒ¢ç ç©¶æã®ã³ãããŠã€ã«ã¹ã¯ãSARS-CoV-2ãš96.2ïŒ ã®åäžæ§ãæã£ãŠããŸãã
æ®ãã®3.8%ã®å·®ç°ã®ã»ãšãã©ãããã®ç¹ç°ãªã¹ãã€ã¯ãå ããŠããŸãã
å¥åŠãªããšã«ããã®ã¹ãã€ã¯ã«ã¯ä»ã®ã²ãã ã«ã¯æ®ã©ãªãè€æ°ã®æ°èŠå€ç°ãããã®ã§ãã
èªç¶é²åã§ã¯ãçªç¶å€ç°ã¯ã²ãã äžã«åçã«ååžããŠãããšäºæ³ãããŸãã
ã§ãããäºå®äžãã¹ãŠã®çªç¶å€ç°ãã¹ãã€ã¯ã§èµ·ãã£ãŠãããšããäºå®ããããããã®ç§åŠè ã¯ã·ãŒã»ãŒã³ã°ãªå士ãåéããæŠæŒ¢ç ç©¶æã®ã³ãããŠã€ã«ã¹ãSARS-CoV-2ã®çŽæ¥ã®ç¥å ã§ããããã®æ°ããã¹ãã€ã¯ã¯å·¥åŠçã«ç§»æ€ããããã®ã§ã¯ãªãããšèããã®ã§ãã
ããããç 究宀ã§ã®éºäŒåæäœã®çè·¡ã¯èŠã€ãããŸããã§ããã
å€ãã®å°éå®¶ã¯ãããªãã¯ææã®æè¡ã䜿ã£ãŠãç 究宀ã§ã®éºäŒåæäœã®çè·¡ãæ¶ããªãããæ°ããã³ãããŠã€ã«ã¹ã®ã¹ãã€ã¯ãçµã¿ç«ãŠãããšãã§ããã®ã§ã¯ãªãããšèããŠããŸãã
ãã®æ°ããç ç©¶ã¯ãé£éŠæ¿åºãè³éæäŸããç ç©¶ãšãäžççãªãã³ãããã¯ãšãçµã³ã€ããçç©åŠçãªè»è·¡ãã€ãªããã®ã§ãã
ãã®è¶³è·¡ã¯ãããŒã¹ã«ãã©ã€ã倧åŠãã£ãã«ãã«æ ¡ïŒUNCïŒãšç±³åœç«ã¢ã¬ã«ã®ãŒææçç ç©¶æ(NIAID)ã«çŽæ¥ã€ãªãã£ãŠããŸãã
ãã®ç ç©¶ã®èè ã§ãããã¥ãŒã¯å€§åŠããŽã¥ã«ããã«ã¯å€§åŠã¯ãªããã¯ããã³äŒæ¥ã°ã«ãŒãã®ç ç©¶è ããŒã ã¯ãã¢ããé žã³ãŒãã«ç¹åŸŽçãªãµã€ã³ãç¹å®ããŸããã
ãã®æ¶ããªãèžè¡åã¯ãããªãã¯ææã®ãããŒã»ã·ãŒãšã ãã®æ¹æ³è«ããããçãŸããªãã£ãã®ã§ãã
æšå¹Žã®æ¥ã«ããªãã¯ææèªèº«ã¯ã€ã³ã¿ãã¥ãŒã§ããã³ãããã¯ãå§ãŸã£ãæã«åœŒã®ãããã³ã«ã䜿ã£ãŠããã®ã¯ãäžçã§2ã3ã®ç ç©¶æã ãã§ãã£ãããšãåçœããŸããã
ãã®ç ç©¶ã®èè ãã¡ã®çµè«ã¯ãæ°åã³ãããŠã€ã«ã¹ã®äžã«ãŠããŒã¯ãªéšäœãããããšãæ ¹æ ã«ããŠããŸãã
ãã®éšäœãããããšã§ããå¶éé µçŽ ããšåŒã°ããç¹æ®ãªé µçŽ ãDNAãç¬èªã®å€§ããã®ãããã¯ã«åæãããããããŠã€ã«ã¹ã²ãã ã®æ£ããé åºã«çž«ãåããããããšãã§ããã®ã ãšèšããŸãã
åºæ¬çã«ã¯ãããªãã¯ææã®æè¡ã¯ããéºäŒåã®èªåœãã«ãŠããŒã¯ãªç¶Žããæ®ããŸãã
ãã®æ°ããåèªã«ã¯ãå¥åŠãªç¶Žãã®éžæããå«ãŸããŠãããå žåçãªãŠã€ã«ã¹ã®èªåœãšåŸ®åŠã«åºå¥ãããã®ã§ãã
ããªãã¯ææã® ãããŒã»ã·ãŒãšã ãæè¡ã¯ããŠã€ã«ã¹ã®ã¿ã³ãã¯è³ªã«å€æŽãå ããããšãªããé¢é£ããéºäŒåéã®ãŠã€ã«ã¹é åã«ããã®ãã㪠ãç¶Žããã®å€åãç®ã«èŠããªãããã«ç¹ã蟌ãã§ããŸãã®ã§ãã
ããã¯ãèšèã®æå³ãå€ããã«ãç¶Žãããå€ãããããªãã®ã§ãäœæ°ãªãèããŠãã人ã¯ãã®éãã«æ°ã¥ãããšã¯ãªãã§ãããã
ç ç©¶ããŒã ã¯ãç§åŠææ»ã®ããã®éå ·ã䜿ã£ãŠãå®éšå®€ã®æ¹ãããè£åãSARS-CoV2ã²ãã ã®åŸ®çްãªãã¹ãã«ã®éããããããŒã·ãŒã ãææ³ã§æãèµ·ãããŸããã
è±åœäººã "color"ã"manoeuvre"ã"paediatric "ãã©ã®ããã«ç¶ŽãããèããŠã¿ãŠãã ããã
ïŒã¢ã¡ãªã«è±èªã§è²ãæå³ããåèªã¯Colorãšç¶Žããã€ã®ãªã¹è±èªã§è²ãæå³ããåèªã¯Colourãšç¶ŽãïŒ
ããåèªã®ç¶Žããéžæããããšã§ããã®åèªã®åºèº«åœãç¥ãããšãã§ããŸãã
åæ§ã«ããŠã€ã«ã¹ã®é åã®ã»ãšãã©æ°ã¥ããªããããªå€åããããã®ãŠã€ã«ã¹ãå®éšå®€ã§äœããããã®ã§ããããšããããã®ã§ãã
ããªãã¯ææã¯èªåã®ã·ãŒã ã¬ã¹ã»ã©ã€ã²ãŒã·ã§ã³æè¡ãã·ãŒã»ãŒã³ã°ãªå士ãšå ±æããããšã§ãæŠæŒ¢ãŠã€ã«ã¹ç ç©¶æïŒWIVïŒãæ°åã³ãããŠã€ã«ã¹ã®çµã¿ç«ãŠã«å¿ èŠãªããã»ã¹ã®å¿ èŠãªèŠçŽ ã®å šãŠãä¿æããŠããããšãä¿èšŒããŸããã
ãšã³ãã«ã¹ã»ã¢ã©ã€ã¢ã³ã¹ã®æªåé«ãDEFUSEææ¡ã«ã¯ãåãæè¡ã詳现ã«èšè¿°ãããŠããã
ïŒ2018幎ã«åœé²é«çç ç©¶èšç»å±ïŒDARPAïŒã«æåºããããã®ïŒ
äžçã¯ä»ãSARS-CoV2ããã©ã«ãã»ããªãã¯ææãç±³åœæ¿åºã®è³éæäŸãåããŠéçºããæè¡ã§çæããã人工çãªå®éšå®€ã§ã®åµé ç©ã§ããããšã蚌æããããšãã§ããŸãã
æ°åã³ããã®ãã³ãããã¯ã«ãã£ãŠå·ã€ããã¯ã©ã€ã¢ã³ããåŒè·ããæ€å¯å®ãšæ°éåŒè·å£«ã¯ãããŸã決å®çãªèšŒæ ãæã£ãŠããã
ãã®æ°åã³ããã®éå£ã¯äººé¡ã«åããããŠããŸãã
æ³å»åŠè ã¯ä»ããã®éã®åŒãéããããããã ãæ£ç¢ºãªæçŽãæ¡åããããšã«æåããŸããã
ãã®æçŽã¯NIAIDãšããŒã¹ã«ãã©ã€ã倧åŠã®ãã®ãªã®ã§ãã
ããªãã¯ææã¯ãã¡ãŠãæ°ã®ãæ°ã«å ¥ãã®æ©èœç²åŸç§åŠè ã§ããã
ããªãã¯ææãšåœŒã®ç 究宀ã«å¯ŸããNIAIDããã®è³éæŽå©ã¯152ä»¶ã2å5åäžãã«ã«ããªããŸãã
ãããã®é£éŠæ¿åºã®å©æéã«ãã£ãŠãããªãã¯ææã¯æ©èœç²åŸç§åŠã®äžççæå°è ã«ãªã£ãã®ã§ãã
æšæºçãªããæ¹ã§ã¯ãããŒã¹ã«ãã©ã€ã倧åŠãã£ãã«ãã«æ ¡ïŒUNCïŒã¯åœç«è¡çç ç©¶æïŒNIHïŒããããªãã¯ææãžã®å©æéã®4åã®1ãã2åã®1ã ã管çè²»ããšããŠèªèº«ã®ãã±ããã«å ¥ããŠããããã§ãã
ãããã®å·šé¡ãªæ¯æãã¯ãããªãã¯ææã®ç¡è¬ãªå®éšã圌ã®å±éºãªæè¡ããç±³åœè°äŒã®èª¿æ»å®ããããšããã®ãæ¯ç§å»é¢ããããå®å šæ§ã®äœããå®å šãããã³ã«ãšææãå·¥äºã§ç¥ãããäžåœè»ã®ç ç©¶æã«ç§»è»¢ãããšããç©è°ãéžã決å®ã«ãUNCãç®ãã€ã¶ãåæ©ã«ãªã£ãã®ã§ãããã
ãã®ãããªçãããè¡çºãå¯èœã«ããUNCã®åœ¹å²ã¯ãé倱責任ã容æã«çããããäžççãªãã³ãããã¯ãåŒãèµ·ããããããããŸããã
UNCãšNIAIDã®è²¬ä»»ã¯ä»ãæããã§ãã
ããããæŠæŒ¢ç ç©¶æãæ°åã³ããã®åå ãšãªã£ãæªç©ãäœãåºãããšãã確蚌ã¯ããã®ã§ããããïŒ
èç©ããã蚌æ ã¯ãæŠæŒ¢ã®ç ç©¶æãããªãã¯ææã®æ¹æ³è«ãçšããŠãæ°åã³ããã®ãã³ãããã¯ãåŒãèµ·ããããã¡ã©ãŠã€ã«ã¹ãäœãäžããããšã匷ã瀺åããŠããŸãã
ããããããã€ãã®æ¬ ããŠããããºã«ã®ããŒã¹ãããããããã®å±éºãªãããžã§ã¯ããæŠæŒ¢ã®ç ç©¶æã§è¡ãããããšãæç¢ºã«èšŒæããããšã¯ã§ããŸããã
ã©ã³ã»ããå§å¡äŒã®å ±åæžãçµè«ä»ããããã«ãå ¬éãããé»åã¡ãŒã«ã¯ãNIHã®ãã©ã³ã·ã¹ã»ã³ãªã³ãºå士ãNIAIDã®ãã¡ãŠãæ°ããšã³ãã«ã¹ã»ã¢ã©ã€ã¢ã³ã¹ã®ããŒã¿ãŒã»ãã¹ã¶ãã¯æ°ããããã®çµµã宿ã§ãããããªæ å ±ã®å ¬éãæå¶ããããã«ãã·ãŒã»ãŒã³ã°ãªå士ãšäžåœåœå±ãšååãç¶ããŠããããšã瀺ããŠããŸãã
ãæåŸ ãã ããã
ïŒåŒçšãããŸã§ïŒ
ãã®èšäºã¯çŸåšã®äžçã®ç¶æ³ãæ ¹æ¬ããã²ã£ããè¿ãåããããŸãã
ã©ãããå®¶æèŠªæããå人ããè¿æãããäŒç€Ÿã®ååãªã©ãããã人ãã¡ã«å ±æããŠæ°£ã¥ããä¿ããŠãã ããã
ããªãããæ¡æ£ã¹ããŒã«ãŒã«ãªãããšã§ãäžçãã²ã£ããè¿ãéåºŠãæ©ãŸããŸãã
ã©ããåæ°ãåºããŠäžæ©ãèžã¿åºããŠãããªãã®å€§äºãªäººãã¡ã«æããŠãããŠãã ããã
ãã¬ãããèŠãªã人ãã¡ã«ã¯å±ããªãæ å ±ã§ãã
ãããªéŠ¬é¹¿ãã話ã¯ä»ããã§çµããã«ããŠãåäŸãã¡ãæããŸãããïŒ
æ¢ã«ã¯ã¯ãã³ã売ã£ãŠããŸã£ãæ¹ã¯ããã¡ãã®æ¹æ³ã§è§£æ¯ããããšãã§ããããç¥ããŸããã
ãã®èšäºã«ã€ã€ããããŠãããããšããã®èšäºãèªãŸãã確çãé«ãŸããŸãã
SNSã§ã®æ¡æ£ã«ããååããããããé¡ãããŸãð
æåŸãŸã§ãèªã¿é ãããããšãããããŸããã
åã®å·ç掻åã®è³éã¯ãéã®è³Œå ¥ä»£è¡ãããåºãŠããã®ã§ãäžçŽæ«ã«å¯Ÿããåãããã€ã€ã掻åãå¿æŽããŠãããããšãéåžžã«å¬ããã§ãã
ãããããé¡ãããŸãð
ãããããã°ããã¡ãã®èšäºãã©ããã